Resection Rate Of Locally Advanced Pancreatic Cancer In Gemcitabine Plus Nab-Paclitaxel Versus Folfirinox.
JOURNAL OF CLINICAL ONCOLOGY(2021)
Abstract
381Background: There is no established treatment for locally advanced pancreatic cancer (LAPC), but by utilizing the regimens approved for metastatic pancreatic cancer, hope remains for rendering t...
MoreTranslated text
Key words
advanced pancreatic cancer,pancreatic cancer,gemcitabine,nab-paclitaxel
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined